Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q2 2022 vs. Q1 2022
How the institutions holding Alterity Therapeutics Ltd changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 13 | 10 | −3 |
| Shares | 780.7K | 725.7K | −55.1K (−7.1%) |
| Value | $643.0K | $441.0K | −$202.0K (−31.4%) |
New holders (2)
Institutions that held Alterity Therapeutics Ltd at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 11,384 | $6.00K | 0.00% |
| CoreCap Advisors, LLC | 216 | $0 | 0.00% |
Sold out (5)
Institutions that held Alterity Therapeutics Ltd at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 23,576 | $19.0K |
| Virtu Financial LLC | 19,590 | $16.0K |
| UBS Group AG | 10,487 | $9.00K |
| Two Sigma Securities, LLC | 10,206 | $8.00K |
| TCWP LLC | 7,750 | $6.00K |